LINC02193

Across TCGA pan-cancer cohorts, LINC02193 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02193 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC02193 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02193 expression acts as an unfavorable survival marker, although some lineages such as UCS and THCA show a favorable association.

UCS, ACC, and KIRC are the cancer types where LINC02193 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Quartile	II,III,IV	0.686	0.186	.001	50	view →
ACC	DFS	Quartile	II,III,IV	0.131	0.778	.001	42	view →
KIRC	DFS	Median	II,III,IV	0.329	0.640	<.001	31	view →
LIHC	DFS	Median	All	0.357	0.510	<.001	31	view →
THCA	OS	Median	II,III,IV	1.000	0.330	.003	30	view →
SKCM	OS	Quartile	All	0.386	0.246	.013	18	view →
GBM	OS	Quartile	All	0.316	0.545	.001	16	view →
ESCA	OS	Tertile	IV	0.219	0.864	.024	12	view →
KICH	DFS	Tertile	II,III,IV	0.640	1.000	.012	10	view →
CHOL	DFS	Quartile	All	0.231	0.761	.010	6	view →
STAD	OS	Tertile	III,IV	0.750	0.373	.029	6	view →
LUAD	OS	Quartile	II,III,IV	0.770	0.557	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02193–UCS (DFS)

Open the UCS breakdown →